1-3 of 3
cerebellar diseases
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Characterizing Inclusion and Exclusion Criteria in Clinical Trials for CAR-T Cellular Therapy Among Adults with Hematologic Malignancies

Jordon Jaggers, Heidi D. Klepin, MD, Tanya M. Wildes, MD, Rebecca L. Olin, MD, Andrew S. Artz, MD, Sarah A Wall, MD, Samantha Jaglowski, MDMPH, Basem M. William, MRCP,MD, Don M. Benson, Jr., MD PhD, Ashley E. Rosko, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5819.
https://doi.org/10.1182/blood-2019-131504
Published: 2019
Journal Articles

Dose-Adjusted Rituximab Mini-CYVE (CYtarabine bolus, VEpeside and dexamethasone) for Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma Not Eligible for High Dose Therapy

Yolla EL Dakdouki, Jean-Marie Michot, MD, Julien Lazarovici, MD, Khalil Saleh, MD, David Ghez, MD PhD, Claude Chahine, MD, Loic Verlingue, Christophe Willekens, MD, Veronique Vergé, Christophe Ferme, MD, Alina Danu, MD, Vincent Ribrag, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2847.
https://doi.org/10.1182/blood.V130.Suppl_1.2847.2847
Published: 2017
Journal Articles

Chronic Aluminum Toxicity Due to Intravenous Substance Abuse Managed with Deferoxamine Chelation Therapy: Case Report.

Gayatri M. Sreenivasan, MD, Raymund L.M. Yong, MD, Dan Holmes, MD
Journal: Blood
Blood (2004) 104 (11): 3695.
https://doi.org/10.1182/blood.V104.11.3695.3695
Published: 2004